Inhibiting glycosphingolipid glycosyltransferase activity prevents cardiac hypertrophy in apoE-/- mice fed a western diet

Djahida Bedja, Sumita Mishra, Christine Amuzie, David Kass, Alberto Avolio, Subroto Chatterjee

    Research output: Contribution to journalMeeting abstract

    Abstract

    Background: Although diet enriched in high fat and cholesterol can induce cardiac hypertrophy, little is known about the role of glycosphigolipids and glycosyltransferases contributing to this phenotype. Herein, using transgenic apo E-/- mice fed a high fat and cholesterol diet we show that treatment with a glycosphingolipid inhibitor blunts cardiac hypertrophy. Methods and Results: Male apoE-/- mice were fed a western diet (20% fat and 1.25% cholesterol) from 12 weeks of age till 36 weeks with and without D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) daily by oral gavage (vehicle alone, 5 mpk and 10mpk) . At 12 week, 20 week and 36 week, trans -thoracic echocardiography were performed in conscious mice using an ultrasound system (n=5 in each group). Mice were euthanized once maladaptive cardiac hypertrophy time point is reach. Tissues such as the heart were harvested for were harvested for histochemical, biochemical, and molecular analysis to ascertain the effects of treatment on glycosphingolipid glycosyltransferase activity, gene/protein expression. We observed an age-dependent increase in the left ventricular mass (LVmass) and decline in fractional shortening indicative of cardiac hypertrophy and dysfunction which worsens with western diet. This was accompanied by increased gene expression for atrial natriuretic protein, Brain-type natriuretic protein, and increased protein expression of transforming growth factor, MAPK and AKT-1. Masson’s trichrome staining revealed hypertrophy in cardiomyocytes and extensive fibrosis. In contrast, treatment with D-PDMP preserved fractional shortening and the left ventricular mass to control levels over a 6 month treatment period. Also, the level of various cardiac glycosphingolipids and glycosyltransferases were decreased to control levels. Conclusion: Treatment with a glycosphingolipid glycosyltransferase inhibitor blunts cardiac hypertrophy in apoE-/- mice fed a western diet.
    Original languageEnglish
    Number of pages1
    JournalFASEB Journal
    Volume28
    Issue numberSuppl. 607
    Publication statusPublished - 2014
    EventExperimental Biology Meeting - San Diego, United States
    Duration: 26 Apr 201430 Apr 2014

    Fingerprint

    Dive into the research topics of 'Inhibiting glycosphingolipid glycosyltransferase activity prevents cardiac hypertrophy in apoE-/- mice fed a western diet'. Together they form a unique fingerprint.

    Cite this